Repeated failure of the bio-prosthetic aortic valve or Mitral valve, which raises the chances of fatality or severe complications in patients of symptomatic heart disease, has lead to a new breakthrough in artificial valve technology. The US Food and Drug Administration (FDA) recently approved the use of Edward Lifescience LLC’s Sapien 3 Transcatheter Heart Valve,